Market Overview:
The global pleural effusions treatment market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The market growth is attributed to the increasing incidence of pleural effusions, rising geriatric population, and technological advancements in the field of pleural effusion treatment. Based on type, the thoracentesis segment accounted for the largest share of the global pleural effusions treatment market in 2017. This segment is expected to grow at a CAGR of 5.9% from 2018 to 2030 due to increasing use of thoracentesis as a minimally invasive procedure for diagnosis and treatment of pleural effusions. Based on application, hospitals accounted for the largest share of the global pleural effusions treatment market in 2017.
Product Definition:
Pleural effusions are excess fluid that accumulates in the pleural space, the thin membrane that lines the lungs and chest cavity. The most common cause of a pleural effusion is heart failure, which can cause fluid to leak from blood vessels in the lungs. Other causes of a pleural effusion include pneumonia, cancer, and cirrhosis of the liver.
Pleural effusions can be treated with diuretics (drugs that increase urine output) to help rid the body of excess fluid. If there is a significant amount of fluid present, draining it may be necessary.
Thoracentesis:
Thoracentesis, also known as vacuum-assisted thoracic extraction (VATE) is a minimally invasive procedure used to remove fluid from the pleural cavity. It is most commonly used for treating fluid accumulation in the middle or lower part of the chest due to conditions such as emphysema or pneumonia. Thoracentesis can be performed through two approaches; open thoracentesis and closed thoracentesis.
Pleurodesis:
Pleurodesis is a surgical procedure used to treat lung cancer. It involves the destruction of some lung tissue in order to reduce the size of the tumor. This treatment is done before chemotherapy or radiation therapy and it helps in reducing complications that may occur during these therapies such as pneumothorax (collapse of a lung), bleeding, and infection.
Application Insights:
The others segment held the largest share of the global market in 2017. This is due to an increase in patients suffering from various conditions such as tuberculosis, lung cancer and other malignant tumors. According to estimates published by WHO, globally around 1 million people die from TB each year and this number is expected to rise by about 2 million annually over the next four years. Thus, increasing incidence of pleural effusion has become a major concern for clinicians across the globe which encourages them to develop new treatment methods rapidly.
Based on application, the market has been segmented into hospitals & clinics, others and private practices/hospitals alone. Hospitals & clinics are estimated to be at a higher growth rate than other segments owing to their abilityto offer advanced treatments with reduced hospital stay compared withothers such as private practices or hospitals overseas for instance U.K.
Regional Analysis:
North America dominated the global market in 2017 owing to the increasing prevalence of lung cancer, rising number of surgeries, and growing awareness about pleural effusions treatment. In addition, presence of well-established healthcare facilities and highly developed healthcare infrastructure is also expected to drive growth during the forecast period.
Asia Pacific is estimated to be fastest-growing region during the forecast period due to factors such as improving economic status and rapid development in various countries such as China & India. Moreover, an increase in road accidents that result intoneumothoraxes are also anticipated to boost regional growth over the forecast period.S.
Growth Factors:
- Increasing incidence of pleural effusions
- Growing awareness about pleural effusions and its treatment options
- Rising demand for minimally invasive procedures for the treatment of pleural effusions
- Technological advancements in the field of pleural effusion treatment
- Growing number of clinical studies on new therapies for the treatment of pleural effusions
Scope Of The Report
Report Attributes
Report Details
Report Title
Pleural Effusions Treatment Market Research Report
By Type
Thoracentesis, Pleurodesis, Pleuroperitoneal Shunt, Others
By Application
Hospitals, Clinics, Others
By Companies
B. Braun, Nouvag, Oakworks Medical, Heyer Medical, Smith Medical, Biometrix, Maxer, Redax, Bicakcilar, Grena
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Pleural Effusions Treatment Market Report Segments:
The global Pleural Effusions Treatment market is segmented on the basis of:
Types
Thoracentesis, Pleurodesis, Pleuroperitoneal Shunt, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- B. Braun
- Nouvag
- Oakworks Medical
- Heyer Medical
- Smith Medical
- Biometrix
- Maxer
- Redax
- Bicakcilar
- Grena
Highlights of The Pleural Effusions Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Thoracentesis
- Pleurodesis
- Pleuroperitoneal Shunt
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pleural Effusions Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pleural effusions are fluid accumulations in the pleural space, which is a cavity between the lungs and chest wall. Pleural effusions can be caused by a variety of conditions, including pneumonia, tuberculosis, and empyema. Treatment typically involves draining the fluid accumulation through a catheter inserted into the pleura.
Some of the major companies in the pleural effusions treatment market are B. Braun, Nouvag, Oakworks Medical, Heyer Medical, Smith Medical, Biometrix, Maxer, Redax, Bicakcilar, Grena.
The pleural effusions treatment market is expected to grow at a compound annual growth rate of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pleural Effusions Treatment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pleural Effusions Treatment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pleural Effusions Treatment Market - Supply Chain
4.5. Global Pleural Effusions Treatment Market Forecast
4.5.1. Pleural Effusions Treatment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pleural Effusions Treatment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pleural Effusions Treatment Market Absolute $ Opportunity
5. Global Pleural Effusions Treatment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pleural Effusions Treatment Market Size and Volume Forecast by Type
5.3.1. Thoracentesis
5.3.2. Pleurodesis
5.3.3. Pleuroperitoneal Shunt
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pleural Effusions Treatment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pleural Effusions Treatment Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pleural Effusions Treatment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pleural Effusions Treatment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pleural Effusions Treatment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pleural Effusions Treatment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pleural Effusions Treatment Demand Share Forecast, 2019-2026
9. North America Pleural Effusions Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pleural Effusions Treatment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pleural Effusions Treatment Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pleural Effusions Treatment Market Size and Volume Forecast by Type
9.7.1. Thoracentesis
9.7.2. Pleurodesis
9.7.3. Pleuroperitoneal Shunt
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pleural Effusions Treatment Demand Share Forecast, 2019-2026
10. Latin America Pleural Effusions Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pleural Effusions Treatment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pleural Effusions Treatment Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pleural Effusions Treatment Market Size and Volume Forecast by Type
10.7.1. Thoracentesis
10.7.2. Pleurodesis
10.7.3. Pleuroperitoneal Shunt
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pleural Effusions Treatment Demand Share Forecast, 2019-2026
11. Europe Pleural Effusions Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pleural Effusions Treatment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pleural Effusions Treatment Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pleural Effusions Treatment Market Size and Volume Forecast by Type
11.7.1. Thoracentesis
11.7.2. Pleurodesis
11.7.3. Pleuroperitoneal Shunt
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pleural Effusions Treatment Demand Share, 2019-2026
12. Asia Pacific Pleural Effusions Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pleural Effusions Treatment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pleural Effusions Treatment Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pleural Effusions Treatment Market Size and Volume Forecast by Type
12.7.1. Thoracentesis
12.7.2. Pleurodesis
12.7.3. Pleuroperitoneal Shunt
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pleural Effusions Treatment Demand Share, 2019-2026
13. Middle East & Africa Pleural Effusions Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pleural Effusions Treatment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pleural Effusions Treatment Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pleural Effusions Treatment Market Size and Volume Forecast by Type
13.7.1. Thoracentesis
13.7.2. Pleurodesis
13.7.3. Pleuroperitoneal Shunt
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pleural Effusions Treatment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pleural Effusions Treatment Market: Market Share Analysis
14.2. Pleural Effusions Treatment Distributors and Customers
14.3. Pleural Effusions Treatment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. B. Braun
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Nouvag
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Oakworks Medical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Heyer Medical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Smith Medical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Biometrix
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Maxer
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Redax
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Bicakcilar
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Grena
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
